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The Vibrio cholerae transcriptional regulator ToxR is
anchored in the cytoplasmic membrane by a single trans-
membrane segment, its C-terminal domain facing the peri-
plasm. Most of its N-terminal cytoplasmic domain shares
sequence similarity with the winged helix–turn–helix
(wHTH) motif of OmpR-like transcriptional regulators.
In the heterologous host Escherichia coli ToxR activates
transcription at the V.cholerae ctx promoter in a
dimerization-dependent manner, which has led to its
employment as a genetic indicator for protein–protein
interactions.However, althoughofferingabroaderpotential
application range than other prokaryotic two-hybrid
systems described to date, ToxR has so far only been used
to study interactions between heterologous transmembrane
segments or to monitor homodimerization of C-terminal
fusion partners in the periplasm and the cytoplasm of
E.coli. Here we show that the ToxR-system also allows the
detection of heterodimerization in both cellular compart-
ments of E.coli. In addition, to better understand ToxR’s
mode of action at ctx in E.coli, we have investigated the
minimal requirements for its function as a transcriptional
activator. We show that the wHTH motif of ToxR’s N-
terminal domain constitutes the minimal structural element
required to activate transcription at ctx inE.coliwhen fused
to a dimerizing protein module.
Keywords: DNA binding/leucine zipper/protein–protein
interaction/ToxR/two-hybrid system
Introduction
In the human pathogen Vibrio cholerae, the signal transduction
protein ToxR functions as a global transcriptional regulator in
a complex regulatory cascade that controls the coordinate
expression of virulence genes, including the ctxAB cholera
toxin genes. ToxR is the prototype of a small unique family
of regulatory proteins that are localized to the cytoplasmic
membrane and yet regulate gene expression by binding
DNA and activating transcription. The bitopic protein is
anchored in the membrane by a single membrane-spanning
segment, its N- and C-terminal domains facing the cytoplasm
and the periplasm, respectively. Much of the cytoplasmic
domain shares sequence similarity with the DNA binding/
transcription activation winged helix–turn–helix (wHTH)
motif of OmpR-like transcriptional activators (Martı´nez-
Hackert and Stock, 1997; Krukonis et al., 2000).
The transcriptional activation of the ctxAB genes in
V.cholerae only indirectly involves ToxR (DiRita et al., 1991;
Higgins et al., 1992). In the heterologous host Escherichia
coli, in contrast, ToxR is capable of directly activating
transcription at ctx (Miller and Mekalanos, 1984) (Figure 1).
The ctx promoter is characterized by a heptameric DNA
Fig. 1. The ToxR-based two-hybrid system for the detection of protein–protein
interactions in the E.coli periplasm (A) and cytoplasm (B). In fusion with non-
interacting heterologous protein modules (diamonds), the membrane-anchored
(ToxR0) and the soluble [ToxR0(DTM)] N-terminal ToxR domains (circles)
remain monomeric and transcription of the lacZ gene under ctx promoter (Pctx)
control is not activated. The interaction of dimerizing heterologous fusion part-
ners (squares) leads to the dimerization of the N-terminal ToxR domains and, as a
result of dimerization, to activation of lacZ transcription at ctx.
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element (TTTTGAT) located 56 bp upstream of the transcrip-
tion start site and directly repeated 3–8 times, depending on the
V.cholerae strain. At least three copies of the heptad and addi-
tional sequences near the 35 promoter region are required for
binding and transcriptional activation of ctx by ToxR (Miller
et al., 1987; Pfau and Taylor, 1996). In E.coli, ToxR’s function
as a transcriptional activator of ctx furthermore requires the
dimerization of its N-terminal DNA-binding domain. This was
first deduced from the finding that the homodimeric enzyme
alkaline phosphatase could functionally substitute for the
periplasmic ToxR domain (Miller et al., 1987; DiRita and
Mekalanos, 1991). Later studies supported the dimerization
model by showing that the DNA-binding domain of phage
l cI repressor dimerizes and represses transcription from
a lambda OR1PR:lacZY reporter fusion in E.coli when N-
terminally fused to ToxR (Dziejman and Mekalanos, 1994).
ToxR’s modular organization and its dimerization-dependent
function as transcriptional activator of ctx in E.coli allow for its
use as a genetic indicator for protein–protein interactions.
ToxR’s periplasmic domain and its transmembrane segment
can be replaced by heterologous protein modules or transmem-
brane segments, respectively, allowing the analysis of protein
interactions and protein stability in the periplasm (Figure 1A)
and also of interactions between transmembrane segments
(Kolmar et al., 1994, 1995a,b; Langosch et al., 1996; Russ
and Engelman, 1999). In addition, ToxR has been demonstrated
to be of use for the identification of protein interactions in the
cytoplasmic compartment of E.coli using variants of ToxR that
lack the transmembrane segment (Kolmar et al., 1995a)
(Figure 1B). In these studies, either a chromosomal ctx::lacZ
(Figure 1) or a plasmid-encoded ctx::chloramphenicol acetyl
transferase reporter fusion served to measure ToxR activity
(Kolmar et al., 1994; Russ and Engelman, 1999).
Allowing the assessment of protein interactions in the inner
membrane and in both cellular compartments of E.coli, ToxR
provides a broader potential application range than existing
prokaryotic two-hybrid systems. So far, however, ToxR’s
technical utility to detect protein–protein interactions in the
cytoplasmic and periplasmic compartments has only been
demonstrated using homodimerizing model proteins (Kolmar
et al., 1995a). In this study, we show that the ToxR-system is
also applicable to monitor asymmetric interactions between
heterologous fusion partners in both cellular compartments
of E.coli. Furthermore, to enhance ToxR’s applicability as a
prokaryotic two-hybrid system, a better understanding of its
mode of action at the ctx promoter in E.coli is required. There-
fore, we have investigated the minimal requirements for its
function as a transcriptional activator of ctx in E.coli. We
show that a short hinge region of ToxR, which lies between
the wHTH domain and the transmembrane segment, is respons-
ible for mediating ToxR–ToxR interactions in vitro but is not
required either for specific DNA binding in vitro or for ctx
activation in E.coli. Hence the conserved wHTH motif of
ToxR’s N-terminal DNA-binding domain defines the minimal
structural element required for ToxR-mediated, dimerization-
dependent transcriptional activation at ctx in E.coli.
Materials and methods
Growth media
Luria–Bertani (LB) and dYT media were prepared as described
(Sambrook et al., 1989) and supplemented with 100 mg/ml
ampicillin (Ap) and 25 mg/ml chloramphenicol (Cm) if
required.
Bacterial strains and plasmids
All strains and plasmids used in this study are listed in Table I.
A detailed description of their construction is given in the
Supplementary data available at PEDS Online under ‘Plasmid
constructions’. To study ToxR-mediated transcriptional activa-
tion in vivo, vectors of the pHK series were used in which the
chimeric toxR genes are under transcriptional control of the
V.cholerae toxR promoter (Kolmar et al., 1994). To study
asymmetric protein–protein interactions, pHK-based vectors
carrying two chimeric toxR0 fusion genes including their up-
and downstream transcriptional regulatory sequences were
used, which allow the co-production of both ToxR0 proteins
at balanced molar levels within each cell.
To produce chimeric ToxR proteins and MalE fusion
proteins for purification, plasmids of the pASK- (toxR0 fusion
genes under tet promoter control; Skerra, 1994), the pBSK-
(toxR0 fusion genes under lac promoter control; Stratagene) and
the pMal-c series (malE genes under tac promoter control;
New England Biolabs) were used.
In vivo assay for ToxR-mediated transcriptional
activation and western blot analysis
ToxR-mediated transcriptional activation was assayed by
monitoring b-galactosidase activity from the chromosomal
ctx::lacZ reporter fusion in E.coli FHK12 (Kolmar et al.,
1995a). FHK12 was freshly transformed with equal amounts
of the pHKToxR0 plasmids and plated on LB/Cm plates. Single
colonies were taken and transferred into 5 ml of LB/Cm sup-
plemented with 0.3 mM isopropyl-b-thiogalactoside (IPTG)
and grown for 10–12 h at 30C. b-Galactosidase activity
was then determined from 15 ml of culture as described by
Kolmar et al. (1995a). In addition, samples of these cultures
containing 108 cells were analyzed by western blotting using
MalE-specific antibodies (New England Biolabs; 1:10 000
dilution). Anti-rabbit alkaline phosphatase (Sigma-Aldrich;
1:10 000 dilution) was used as the secondary antibody. The
blots were developed by incubation in reaction buffer (100 mM
Tris–HCl pH 8.8, 100 mM NaCl, 5 mM MgCl2, 37.5 mg/ml
NBT, 150 mg/ml BCIP).
Protein production and purification
MalE, MalEGCN, ToxR0(DTM)MalE and ToxR0(DTM)
MalEGCN were produced from the respective pMal-c and
pBSIISK(–) plasmids in E.coli PD28 (Table I). Cultures
were grown in LB/Ap at 30C and production of the recom-
binant proteins was induced with 0.5 mM IPTG at an OD600 of
0.3–0.5 followed by further incubation for 3–5 h. Cells were
pelleted by centrifugation (4000 g, 40 min, 4C), resuspended
in amylose A buffer (50 mM Tris–HCl, pH 7.5, 2.5 mM b-
mercaptoethanol) with 1 mM PMSF and lysed by French press
treatment and sonication. The cell extract was cleared by cent-
rifugation (15 000 g, 40 min, 4C) and mixed with amylose
resin (New England Biolabs) pre-equilibrated with amylose A
buffer. After 30 min of incubation on ice the mix was centri-
fuged (4000 g, 10 min, 4C) and the supernatant removed. The
amylose resin was washed three times in amylose-wash buffer
(amylose A buffer with 0.5 M NaCl) and once with amylose A
buffer. The MalE fusion proteins were then eluted by incuba-
tion in amylose B buffer (amylose A buffer with 10 mM
F.Hennecke et al.
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maltose) for 30 min on ice and subsequent centrifugation. The
protein containing supernatant was dialyzed and concentrated.
The typical protein yield from this protocol was 8 mg of
MalE or MalEGCN protein per 50 ml of cell culture and
0.25 mg of the ToxR0(DTM) fusion proteins per liter of
cell culture.
The ToxR0(DTM), ToxR0(DTM)GCN, ToxR0(DTM)(DX),
ToxR0(DTM)(DX)GCN, ToxR0(D139–181)(DTM)(DX) and
ToxR0(D139–181)(DTM)(DX)GCN proteins were produced
and purified using the IMPACT expression system (New
England Biolabs). The proteins were produced in fusion
with the Intein-CBD (Intein-chitin-binding domain) protein
from pASK-plasmids in E.coli HS3018 (Table I). Cultures
were grown in LB/Ap at 37C to an OD600 of 0.5 and the
production of the recombinant proteins was induced with
0.2 mg/ml anhydrotetracycline. After growth for a further 2–
3 h, cells were harvested by centrifugation (4000 g, 40 min,
4C), resuspended in CB buffer (40 mM Tris–HCl, pH 8.5, 500
mM NaCl, 1 mM EDTA, 0.1% Triton X-100) supplemented
with 75 units of Benzonase (Merck) and lysed by French press
treatment and subsequent sonication. The cell extract was
cleared by centrifugation (15 000 g, 40 min, 4C) and applied
to a 6–8 ml chitin beads column (New England Biolabs) pre-
equilibrated with CB buffer. The column was washed with CB-
wash buffer (CB buffer with 1 M NaCl), sealed and incubated
for 30 min at room temperature to release ToxR-bound DNA,
Table I. Bacterial strains and plasmids
Strain/plasmid Description/relevant genotype Reference/source
Strain
FHK12 F0 lacIq lacZDM15 proA+B+ ara D(lac-proAB)
rpsL 80dlacDM15 attB::(bla, ctx::lacZ), ApR
Kolmar et al. (1995a)
HS3018 MC4100 malTc-1 DmalE444 Shuman (1982)
PD28 F0 thiA relA araD139 DlacU169 rpsL malTc-1 DmalE444 D(srl-recA)306::Tn10 Duplay et al. (1987)
Plasmids
pASK75 Expression vector, Ptet, ColE1 ori, Ap
R Skerra (1994)
pASKToxR0(DTM)-Int toxR codons 1–182+199–210 (toxR0(DTM)) fused
to the intein-cbda gene in pASK75, ApR
This work
pASKToxR0(DTM)GCN-Int toxR0(DTM)GCN-intein-cbd fusion gene in pASK75, ApR This work
pASKToxR0(DTM)(DX)-Int toxR0(DTM)-intein-cbd fusion gene lacking toxR codons 198–210 in pASK75, ApR This work
pASKToxR0(DTM)(DX)GCN-Int toxR0(DTM)GCN-intein-cbd fusion gene lacking toxR
codons 198–210 in pASK75, ApR
This work
pASKToxR0(D123–181)(DTM)(DX)GCN-Int toxR0(DTM) (DX) GCN-intein-cbd fusion gene lacking toxR codons
123–181 in pASK75, ApR
This work
pASKToxR0(D139–181)(DTM)(DX)–Int toxR0(DTM) (DX)-intein-cbd fusion gene lacking toxR codons
139–181 in pASK75, ApR
This work
pASKToxR0(D139–181)(DTM)(DX)GCN-Int toxR0(DTM) (DX) GCN-intein-cbd fusion gene lacking toxR
codons 139–181 in pASK75, ApR
This work
pBSIISK(–) Expression vector, Plac, Ap
R Stratagene
pBSK(–)ctx-21 ctx promoter fragment in pBSIISK(–), ApR This work
pBSK(–)HELE35Q helE35Q-fragment in pBSIISK(–), ApR This work
pBSKToxR0(DTM)MalE toxR0(DTM)malE fusion gene in pBSIISK(–), ApR This work
pBSKToxR0(DTM)MalEGCN toxR0(DTM)malEGCN fusion gene pBSIISK(–), ApR This work
pHK vector series Expression vector for b-galactosidase assays; P/OtoxR, F1 ori, ColE1 ori, Cm
R Kolmar et al. (1994)
pHKToxR0MalE toxR0malE fusion gene in pHK, CmR Kolmar et al. (1995a)
pHKToxR0MalEGCNb toxR0malEGCN fusion gene in pHK, CmR Kolmar et al. (1995a)
pHKToxR0MalEFos toxR0malEfos fusion gene in pHK, CmR This work
pHKToxR0MalEJun toxR0malEjun fusion gene in pHK, CmR This work
pHKToxR0MalEJunL14F/L21H toxR0malEjunL14F/L21H fusion gene in pHK, CmR This work
pHKToxR0MalEFos/ToxR0MalEJun toxR0malEfos and toxR0malEjun fusion genes in pHK, CmR This work
pHKToxR0MalEFos/
ToxR0MalEJunL14F/L21H
toxR0malEfos and toxR0malEjunL14F/L21H fusion genes in pHK, CmR This work
pHKToxR0(DTM) toxR codons 1–182+199–210 (toxR0(DTM)) in pHK, CmR This work
pHKToxR0(DTM)(DX)c toxR0(DTM) gene with stop codon in position 182 in pHK, CmR Kolmar et al. (1995a)
pHKToxR0(DTM)MalE toxR0(DTM)malE fusion gene in pHK, CmR Kolmar et al. (1995a)
pHKToxR0(DTM)MalEGCNb toxR0(DTM)malEGCN fusion gene in pHK, CmR Kolmar et al. (1995a)
pHKToxR0(DTM)MalEFos toxR0(DTM)malEfos fusion gene in pHK, CmR This work
pHKToxR0(DTM)MalEJun toxR0(DTM)malEjun fusion gene in pHK, CmR This work
pHKToxR0(DTM)MalEJunL14F/L21H toxR0(DTM)malEjunL14F/L21H fusion gene in pHK, CmR This work
pHKToxR0(DTM)MalEFos/
ToxR0(DTM)MalEJun
toxR0(DTM)malEfos and toxR0(DTM)malEjun fusion genes in pHK, CmR This work
pHKToxR0(DTM)MalEFos/
ToxR0(DTM)MalEJunL14F/L21H
toxR0(DTM)malEfos and toxR0(DTM)malEjunL14F/L21H
fusion genes in pHK, CmR
This work
pHKToxR0(DTM)GCNb toxR0(DTM)GCN fusion gene in pHK, CmR Kolmar et al. (1995a)
pHKToxR0(DTM)(DX)GCN toxR0(DTM)(DX)GCN fusion gene in pHK, CmR This work
pHKToxR0(D123–181)(DTM)(DX)GCN toxR0(D123–181)(DTM)(DX)GCN fusion gene in pHK, CmR This work
pHKToxR0(D139–181)(DTM)(DX)GCN toxR0(D139–181)(DTM)(DX)GCN fusion gene in pHK, CmR This work
pMal-c Expression vector, Ptac, ColE1 ori, Ap
R New England Biolabs
pMalcMalE malE gene in pMal-c This work
pMalcMalEGCN malEGCN fusion gene in pMal-c This work
acbd= chitin-binding domain.
bGCN referred to as Zip in Kolmar et al. (1995a).
cReferred to as pHKToxR0(DTM) in Kolmar et al. (1995a).
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which was then removed with 10 volumes of CB-wash buffer.
The column was equilibrated with 10 volumes of DNase buffer
(50 mM Tris–HCl, pH 8.0, 3 mM MgCl2) and incubated in 1
volume of DNase-buffer with 75 units of Benzonase for 30 min
at 37C to digest residual DNA. After washing the column with
10 volumes of CB buffer, three volumes of cleavage buffer (CB
buffer with 150 mM DTT) were applied and the sealed column
was incubated at room temperature for 16–24 h. Finally, the
proteins were eluted with 5 volumes of CB buffer, dialyzed and
concentrated to 5–10 mg/ml. Typical protein yield from this
protocol was 3–6 mg of ToxR0(DTM) fusion protein per liter of
cell culture.
Protein preparations were confirmed to be free of con-
taminating DNA and of residual DNase activity. Protein
concentrations were determined spectrophotometrically with
absorption coefficients calculated according to Pace et al.
(1995).
Gel filtration analysis
Apparent molecular protein weights were determined by gel
filtration on an FPLC Superdex 200 HR 10/30 column (Phar-
macia) at 4C in gel filtration buffer (40 mM Tris–HCl pH 7.5,
500 mM NaCl, 1 mM EDTA) and a flow rate of 0.5 ml/min.
The proteins were applied to the column in 50–100 ml samples
at the concentrations indicated in Table II. Molecular
weight standard proteins (Pharmacia) were used for column
calibration.
Electrophoretic mobility shift assays
The ctx- (209 bp) and hel- (410 bp) DNA fragments were
amplified from the pBSK(–)ctx-21 and pBSK(–)HELE35Q
plasmids by standard PCR using the primer pairs Suctxup
(50-GGAATTCTAGAAGTGAAACGGGGT-30)/SuctxDsig (50-
GGAATTCTAGAAGTGAAACGGGGT-30) and Hellup (50-
GTCGACCCCGGGAAAGTC-30)/Hello (50-CGCGGTTC-
TAGATTATCACAGCCGGCAGCCTCTG-30), respectively.
The fragments were purified from agarose gels and sub-
sequently cleaved with EcoRI and XbaI, respectively (restric-
tion sites underlined), to generate 50-overhangs. After
inactivation of the enzymes by heat treatment, the DNA frag-
ments were radioactively labeled in a standard fill-in reaction
using Klenow DNA polymerase and a[32P]dATP (Sambrook
et al., 1989).
For gel retardation analysis, 50 fmol of radiolabeled DNA
was incubated in 50 ml of shift buffer (40 mM Tris–HCl, pH 7.5,
50 mM NaCl, 1 mM EDTA, 0.1 mM DTT, 5% glycerol, 50 mg/
ml BSA) with 500 ng of salmon sperm DNA (in 56- and 37-fold
excess with regard to ctx- and hel-DNA, respectively) and 0–80
pmol of protein for 30 min at room temperature. The samples
were loaded directly on a 6% TBE polyacrylamide gel
(200·250·1.5 mm) and run overnight with 0.5· TBE running
buffer at room temperature and 4–8 mA. Radiolabeled
DNA was visualized by exposure to X-ray film for 2–12 h
at 70C.
Analysis of protein–DNA interactions by surface plasmon
resonance spectroscopy
The interaction of soluble ToxR proteins with ctx- and
hel-DNA was analyzed by surface plasmon resonance spectro-
scopy (SPR) on a Biacore system 1000 (BIAcore AB) with
biotinylated DNA fragments immobilized on a streptavidin
chip (SA5, BIAcore AB). Interaction was detected by monit-
oring the mass concentration-dependent changes of the refract-
ive index on the sensor surface, expressed as resonance
units (RU).
Biotinylated Bio-ctx- (204 bp) and Bio-hel- (417 bp) DNA
fragments were amplified from the pBSK(–)ctx21 and pBSK
(–)HELE35Q plasmids by standard PCR using the primer pairs
Bioctxup (50-biotin-TCTAGAAGTGAAACGGGG-30)/Suctx-
Dsig and Biohelup (50-biotin-GTCGACCCCGGGAAAG-
TC-30)/Hello, respectively. The fragments were purified
from agarose gels and immobilized on the SA5 sensor chip
by injecting 25 ml of HBS buffer (10 mM HEPES pH 7.4,
150 mM NaCl, 3.4 mM EDTA, 0.005% Tween-20) containing
2.1 pmol/ml Bio-ctx or Bio-hel at a flow rate of 2 ml/min.
Injection of Bio-ctx resulted in 306 RU, injection of Bio-hel
in 253 RU, corresponding to final DNA densities on the chip
surfaces of about 2.1 and 1.0 fmol/mm2, respectively. The
Bio-ctx fragment was immobilized in 2-fold molar excess to
compensate for the 2-fold length of the Bio-hel fragment and
thus to display comparable numbers of potential DNA binding
sites on both chip surfaces.
For interaction studies, 20 pmol of protein in 10 ml of shift
buffer (without BSA) were injected at a constant flow rate of
2 ml/min. The chip surfaces were regenerated by flushing with
10 ml of 1 M NaCl. All solutions used for SPR were filtered
(0.22 mM) and degassed.
Results
Soluble and membrane-anchored heterodimerizing ToxR
derivatives activate transcription at ctx in E.coli
Using the Bence Jones protein REIv and the leucine zipper
domain of the Saccharomyces cerevisiae transcriptional
activator GCN4 (Hope and Struhl, 1987) as model proteins
for homodimerization, it has previously been demonstrated
that the ToxR-system allows the analysis of protein stability
and the detection of symmetric protein interactions in both the
cytoplasm and the periplasm of E.coli (Kolmar et al., 1994,
1995a,b). To examine whether the ToxR system would also be
applicable to detect asymmetric protein interactions in both
cellular compartments, we chose here the leucine zippers of
the transcriptional activators Jun and Fos (O’Shea et al., 1989)
as model proteins for heterodimerization. Since Jun has been
reported also to form homodimers in absence of Fos, we used
Table II. Oligomeric states of ToxR fusion proteins determined by
gel filtration analysis
Protein Calculated Mr Apparent Mr Oligomeric state
MalE 41 592 41 630a Monomer
MalEGCN 45 925 76 770a Dimer
ToxR0(DTM)MalE 63 025 77 560b Monomer
ToxR0(DTM)MalEGCN 67 814 105 250c Dimer
ToxR0(DTM) 21 800 45 783b Dimer
ToxR0(DTM)GCN 26 300 125 170b Pentamer
ToxR0(DTM)(DX) 20 664 40 523b Dimer
ToxR0(DTM)(DX)GCN 24 999 112 876b Pentamer
ToxR0(D139181(DTM)(DX) 16 384 19 196b Monomer
ToxR0(D139181(DTM)
(DX)GCN
20 700 52 481b Dimer/Trimer
Analyzed protein: a50 ml of 0.8 mg protein/ml.
b100 ml of 0.4 mg protein/ml.
c50 ml of 0.2 mg protein/ml.
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the homodimerization-deficient JunLeu14Phe/Leu21His
(JunL14F/L21H) protein (Smeal et al., 1989) as a control. Fur-
thermore, because it has been shown that ToxR derivatives in
which the periplasmic ToxR domain is substituted only by a
short leucine zipper peptide are not stably inserted into the
inner membrane (Kolmar et al., 1995a), we generated tripartite
fusion proteins by placing the monomeric maltose-binding
protein MalE between the transmembrane (ToxR0) or cytoplas-
mic [ToxR0(DTM)] ToxR modules and the C-terminal leucine
zipper peptides (Figure 2B). The ability of these ToxR
chimeras to initiate transcription at the ctx promoter was
then analyzed by measuring the b-galactosidase activity res-
ulting from a chromosomal ctx::lacZ fusion in the E.coli
reporter strain FHK12 (Kolmar et al., 1995a) (Figure 2C).
As a positive control for dimerization, we also re-analyzed
the corresponding membrane-anchored and soluble GCN4
fusion proteins (Kolmar et al., 1995a; Figure 2B and C).
Finally, to allow a quantitative comparison of the transcrip-
tional activities, we examined the stability and the cellular
levels of the ToxR fusion proteins by immunoblotting
(Figure 2D).
In accord with previous results (Kolmar et al., 1995a), both
the membrane-anchored and the soluble homodimerizing
ToxR0MalEGCN and ToxR0(DTM)MalEGCN proteins
exhibited 5–8-fold higher transcriptional activities than the
ToxR0MalE and ToxR0(DTM)MalE proteins although present
in the cells at comparable levels (Figure 2C and D). The latter
proteins mediated b-galactosidase activity slightly above the
background level (FHK12 in Figure 2C). Consistent with the
ability of Fos and Jun to form heterodimers, the co-production
of both the membrane-anchored ToxR0MalEFos/Jun and the
soluble ToxR0(DTM)MalEFos/Jun proteins resulted in signi-
ficant higher b-galactosidase activities than their separate pro-
duction. Moreover, comparable b-galactosidase activities were
obtained by producing the homodimerization-deficient ToxR-
JunL14F/L21H proteins along with their corresponding ToxR-Fos
partners, demonstrating that the ToxR-mediated transcriptional
activation at ctx is not affected by ToxR-Jun/Jun homodimer-
ization but results from the formation of ToxR-Fos/Jun
heterodimers. Noteworthily, the separately produced soluble
ToxR0(DTM)MalEJun and ToxR0(DTM)MalEJunL14F/L21H
proteins were hardly detectable in the cells (Figure 2D),
most likely owing to their degradation by cytoplasmic pro-
teases. The still detectable transcriptional activity of the sol-
uble ToxR0(DTM)MalFos/Jun and ToxR0(DTM)MalFos/
JunL14F/L21H heterodimers suggests that the Jun proteins
are protected from degradation by their interaction with
ToxR0(DTM)MalFos. However, cultures producing the
homodimerization-deficient ToxR0(DTM)MalEJunL14F/L21H
protein together with ToxR0(DTM)MalEFos showed large
variations in b-galactosidase activity (Figure 2C), suggesting
that this ToxR variant is unstable even in presence of its
interaction partner. Finally, while Jun has been reported to
form homodimers in the absence of Fos (Smeal et al.,
1989), not even the membrane-anchored ToxR0MalEJun
protein, which was present in the cells at levels comparable
to ToxR0MalEGCN (Figure 2D), showed detectable trans-
criptional activity. Possibly higher cellular concentrations of
ToxR0MalEJun are required to monitor its homodimerization.
However, overall the above results demonstrate that the ToxR-
system is applicable for the detection of heterodimerization in
both the E.coli cytoplasm and periplasm.
The cytoplasmic DNA-binding domain of ToxR promotes
oligomer formation in vitro
The soluble ToxR0(DTM)MalE and ToxR0(DTM)MalEGCN
proteins and the corresponding variants lacking the MalE
moiety, ToxR0(DTM) and ToxR0(DTM)GCN, respectively,
Fig. 2. Activity of membrane-anchored and soluble, homo- and heterodimer-
izing ToxR derivatives. (A) Modular organization of the V.cholerae signal
transduction protein ToxR. Numbers indicate amino acid positions correspond-
ing to Swiss-Prot accession number P15795. nToxR, N-terminal, cytoplasmic
domain (amino acids 1–182); cToxR, C-terminal, periplasmic domain (amino
acids 199–297); TM, transmembrane segment (amino acids 183–198). (B)
Modular organization of chimeric ToxR proteins. Amino acids 1–210 of ToxR
(termed ToxR0) serve as the reference module in all membrane-anchored ToxR
derivatives. Soluble ToxR derivatives were generated by deletion of the hydro-
phobic transmembrane segment and carry amino acids 1–182 plus amino acids
199–210 of the periplasmic ToxR domain (= region X, indicated by a black box)
as the reference module [termed ToxR0(DTM)]. Linker peptides in ToxR-MalE
derivatives originating from pMal-p are indicated by solid (10 amino acids,
NSSSVPGRGS) and dashed lines (14 amino acids, NSSSVPGRGSIEGR),
respectively. Fos, GCN, Jun, leucine zippers of the transcriptional activators
Fos, GCN4 and Jun, respectively; JunL14F/L21H, homodimerization-deficient Jun
mutant (Smeal et al., 1989); MalE, maltose-binding protein. (C) Transcription
activation at the ctx promoter in E.colimediated by the ToxR derivatives shown
in (B). Each bar represents the specific b-galactosidase activity in crude cell
lysates of at least three independent overnight cultures. Standard deviations are
indicated. Black bar, the plasmid-free reporter strain FHK12 (FH; negative
control); gray bars, membrane-anchored ToxR variants; white bars, soluble,
cytoplasmic ToxR variants. dash, no C-terminal leucine zipper; G, GCN; F,
Fos; J, Jun; Jm, JunL14F/L21H. (D) Immunodetection of ToxR-MalE fusion pro-
teins. Samples corresponding to 108 cells were taken from the cultures analyzed
in C and subjected to western blot analysis using MalE-specific antibodies. The
periplasmic MalE protein serves as an internal control (indicated by an asterisk)
to confirm loading of comparable sample sizes. While the ToxR0MalEGCN
signal was somewhat weaker than the ToxR0MalEJun or ToxR0MalEFos signals
only in this particular experiment, the protein ran with lower electrophoretic
mobility in all experiments for unknown reasons.
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were purified and their apparent molecular weights determined
by gel filtration to confirm their monomeric and dimeric states,
respectively. The maltose-binding protein MalE and a MalE-
GCN fusion protein, which forms homodimers with a KD
below 0.1 mM (Hope and Struhl, 1987; O’Shea et al., 1989),
served as monomeric and dimeric control proteins (Table II).
The analysis confirmed a monomeric state of ToxR0(DTM)-
DTM)MalE and a dimeric state of ToxR0(DTM)MalEGCN.
The ToxR0(DTM) and ToxR0(DTM)GCN proteins, however,
revealed apparent Mr values that correspond to dimeric and
pentameric states, respectively (Table II), suggesting that addi-
tional interaction sites may exist in the ToxR portion of the
fusion proteins. In the ToxR0(DTM)MalE and ToxR0(DTM)
MalEGCN proteins the voluminous MalE moiety may steric-
ally hinder the association of these interaction sites.
The hinge region of ToxR is required for oligomer formation
in vitro but not for activation of ctx transcription
in E.coli
In the soluble ToxR fusion proteins, two regions are possible
candidates for mediating the oligomerization that was observed
in vitro. Firstly, the fusion proteins have been constructed in
such a way that they retain a small portion of the C-terminal
periplasmic domain of ToxR (Kolmar et al., 1995a; amino
acids 199–210 indicated by a black box in Figure 2B and
Figure 3B and referred to as region X). The periplasmic
domain, however, has been suggested to be important for
the dimerization of ToxR in vivo (Dziejman and Mekalanos,
1994) and therefore it may be region X that is responsible for
the in vitro oligomerization of the soluble ToxR fusion pro-
teins. Alternatively, interaction sites responsible for oligomer
formation may exist in the N-terminal cytoplasmic ToxR
module. While its amino acids 20–123 show sequence simil-
arity to the DNA binding/transcription activation wHTH
domain of OmpR-like transcriptional activators (Martı´nez-
Hackert and Stock, 1997; Krukonis et al., 2000) (Figure 3A),
its amino acids 124–181 link the wHTH domain to the trans-
membrane segment (amino acids 182–198) of ToxR. This short
hinge region is present in the soluble ToxR fusion proteins and
might also mediate their oligomerization.
To determine whether or not these two regions, region X and
the hinge region, play a role in ToxR activity and/or in oligo-
mer formation, we generated variants of ToxR0(DTM) and
ToxR0(DTM)GCN lacking region X [ToxR0(DTM)(DX) and
ToxR0(DTM)(DX)GCN, Figure 3B] or lacking both region
X and the hinge region [ToxR0(D124–181)(DTM)(DX)GCN,
ToxR0(D139–181)(DTM)(DX) and ToxR0(D139–181)(DTM)
(DX)GCN, Figure 3B] and investigated their ability to activate
transcription at ctx in E.coli and to form oligomers in vitro.
Whereas the region X deletion mutant ToxR0(DTM)(DX)GCN
exhibited a transcriptional activity comparable to that of
ToxR0(DTM)GCN (Figure 4), no transcriptional activity was
detected for ToxR0(D124–181)(DTM)(DX)GCN, which lacked
the complete hinge region (Figure 3B and data not shown).
Furthermore, all attempts to purify the ToxR0(D124–181)
(DTM)(DX)GCN protein failed (data not shown), sugges-
ting that it was highly unstable. The ToxR0(D139–181)
(DTM)(DX)GCN protein, in contrast, which still contains
the first 16 amino acids of the hinge region (Figure 3B), medi-
ated b-galactosidase activity just as well as ToxR0(DTM)GCN
and ToxR0(DTM)(DX)GCN (Figure 4). Finally, the region X
deletion mutant ToxR0(DTM)(DX) like ToxR0(DTM) showed
no activity (Figure 4). Hence region X neither negatively nor
positively affects the transcriptional activity of soluble ToxR
proteins.
The analysis of the above proteins by gel filtration revealed
that the region X deletion mutants ToxR0(DTM)(DX) and
ToxR0(DTM)(DX)GCN are still able to form dimers and pen-
tamers, respectively (Table II). This indicates that the presence
of region X in the soluble ToxR derivatives is not responsible
Fig. 3. Organization of the N-terminal, cytoplasmic DNA-binding domain of
ToxR. (A) Predicted secondary structure of the wHTH motif in ToxR (according
to Krukonis et al., 2000). Numbers indicate amino acid positions according to
Swiss-Prot accession number P15795. (B) Modular organization of soluble
ToxR deletion mutants. GCN, leucine zipper of the transcriptional activator
GCN4; hinge, hinge region of ToxR; TM, transmembrane segment; X, region X
(amino acids 199–210 of the periplasmic ToxR domain).
Fig. 4. Transcriptional activation at the ctx promoter in E.coli mediated by
soluble region X and hinge region deletion mutants of ToxR. Each bar
represents the specific b-galactosidase activity in crude cell lysates from at
least three independent overnight cultures. Standard deviations are shown.
Black bar, the plasmid-free reporter strain FHK12 (FH, negative control). White
bars, soluble, cytoplasmic ToxR proteins.
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for their ability to oligomerize. In contrast, the apparent Mr
values determined for the hinge region deletion mutants sug-
gest a monomeric state of ToxR0(D139–181)(DTM)(DX) and a
dimeric/trimeric state of ToxR0(D139–181)(DTM)(DX)GCN.
We therefore suggest that the hinge region of ToxR (amino
acids 139–181) is responsible for the ability of the cytoplasmic
ToxR module to dimerize in vitro but is not required for
ToxR-mediated transcriptional activation at ctx in E.coli.
Analysis of DNA binding by soluble ToxR derivatives
To study the requirements for specific DNA binding by
ToxR we analyzed the interaction of ToxR0(DTM) and
ToxR0(DTM)GCN with DNA in electrophoretic mobility
shift assays (Figure 5) and by surface plasmon resonance
(SPR) (Figure 6). For both experimental approaches, an
about 200 bp ctx promoter fragment and an about 410 bp
hel fragment were used as specific and non-specific DNA
probes, respectively. The core sequence (138 bp) in the ctx
fragment is identical with the chromosomal ctx promoter
region in the E.coli reporter strain FHK12 (Kolmar et al.,
1995a) but, in contrast to the ctx promoter region of V.cholerae
(Miller et al., 1987; GenEMBL accession number 00171),
carries an only 7-fold instead of an 8-fold direct repeat of
the heptanucleotide sequence TTTTGAT. The flanking regions
of ctx (30 bp) originate from pMc vector DNA (see Supple-
mentary data, ‘Plasmid constructions’). The hel-DNA frag-
ment corresponds to nucleotides 79–471 of GenBank
accession number V00428, encoding mature hen egg lysozyme
with a G to C mutation in codon 35 (helE35Q). The fragment is
flanked on either side by eight base pairs originating from the
primers used for its PCR amplification (see Supplementary
data, ‘Plasmid constructions’).
In accord with the observed transcriptional activities in vivo,
the mobility shift assays revealed that ToxR0(DTM)GCN binds
to ctx-DNA with higher specificity than ToxR0(DTM)
(Figure 5A). Under the given experimental conditions
(see Materials and methods), first detectable interactions of
ToxR0(DTM)GCN with ctx promoter DNA occurred at a
protein:DNA ratio of 100:1 (Figure 5A, 5 pmol). Increas-
ing protein amounts then resulted in further retardation of the
protein–DNA complexes, until in the presence of >40 pmol
of ToxR0(DTM)GCN high molecular weight aggregates
with strongly reduced electrophoretic mobility were formed.
Fig. 5. Analysis of ToxR0(DTM) and ToxR0(DTM)GCN DNA binding by
electrophoretic mobility shift assays. Radiolabeled (50 fmol) specific ctx
promoter DNA (A) and non-specific helE35Q-DNA (B) were incubated with
indicated amounts of ToxR0(DTM) and ToxR0(DTM)GCN in the presence of
500 ng of cold salmon sperm competitor DNA in a total volume of 50 ml as
described in Materials and methods and analyzed by non-denaturating polyac-
rylamide gel electrophoresis. Arrows indicate the free ctx- and helE35Q-DNA
fragments. The asterisk marks DNA fragments of unknown identity present in
some hel-DNA preparations.
Fig. 6. Analysis of the interaction of ToxR0(DTM) and ToxR0(DTM)GCN with
ctx- (A) and hel- (B) DNA by surface plasmon resonance. Biotinylated ctx- and
hel-DNA-fragments were immobilized on an SA5 sensor chip surface at final
densities of 2.1 and 1.0 fmol/mm2, respectively, as described in Materials and
methods. The indicated proteins (20 pmol) were passed over the DNA-
functionalized sensor chip surfaces at constant flow rates of 2 ml/min. Associ-
ation (Ass.), dissociation (Diss.) and regeneration (Reg.) phases are indicated.
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This shift mode suggests that the ctx fragment provides
multiple binding sites for ToxR and that these binding sites
are occupied by ToxR0(DTM)GCN successively in a con-
centration-dependent manner.
In contrast to ToxR0(DTM)GCN, eight times more protein
(40 pmol) was required to observe complex formation between
ToxR0(DTM) and ctx-DNA. At 40 pmol, however, both
ToxR0(DTM) and ToxR0(DTM)GCN already interacted with
the helE35Q control DNA (Figure 5B), ToxR0(DTM)GCN
again forming high molecular weight aggregates. This suggests
that these complexes rather reflect non-specific binding of
the proteins to ctx and hel DNA, which might occur possibly
because at higher protein concentrations all potential
non-specific binding sites provided by the cold salmon
sperm competitor DNA have been bound. Still, a further
increase in protein concentration resulted in a further shift
of ToxR0(DTM)–ctx complexes (Figure 5A) but not of
ToxR0(DTM)–helE35Q complexes (Figure 6B), suggesting
that ToxR0(DTM) exhibits higher binding specificity for ctx-
than for helE35Q-DNA. Finally, the mobility shift patterns
obtained for binding of the oligomerization-deficient
ToxR0(D139–181)(DTM)(DX)GCN protein to ctx- and
hel-DNA were similar to those obtained for ToxR0(DTM)GCN
DTM)GCN binding to these DNA fragments (data not shown
and Figure 5). Hence the ability to form higher order oligomers
is not required for specific DNA binding by ToxR dimers and
does not affect the binding mode.
The interaction of ToxR0(DTM)GCN and ToxR0(DTM) with
ctx- and helE35Q-DNA was also analyzed by SPR (Figure 6).
The biotinylated DNA-fragments were immobilized on a
streptavidin sensor chip as described in Materials and methods
and the proteins (20 pmol in 10 ml of sample buffer) passed
over the chip surface at a constant flow rate of 2 ml/min.
Injection of ToxR0(DTM)GCN to the ctx chip resulted in a
fast initial association phase that plateaued at about 2000
response units (RU), indicating that the protein rapidly
bound to the ctx fragment until steady state (Figure 6A).
ToxR0(DTM)GCN then dissociated in two phases. Unbound
or loosely attached protein was washed off the surface in a
first rapid dissociation phase, which was followed by a second,
slow dissociation phase that started at 750 RU and very
slowly approached the baseline, indicative of a fairly strong
interaction of ToxR0(DTM)GCN with the ctx fragment. In con-
trast, the sensorgram of ToxR0(DTM) binding to the ctx chip
hardly differs from the buffer control in that a plateau was
reached immediately upon injection, indicating that no or
only little protein bound to the chip surface. Accordingly,
dissociation occurred rapidly back to the baseline level.
Hence ToxR0(DTM)GCN but not ToxR0(DTM) binds with
high affinity to ctx, again suggesting dimerization as the critical
parameter for specific ToxR–DNA interaction. To rule out the
possibility that the ToxR0(DTM)GCN–DNA interaction was
mediated by the GCN component, we also examined ctx bind-
ing by a BlaGCN fusion protein. As for ToxR0(DTM), the
resulting sensorgram did not reveal any specific interaction
of BlaGCN with the ctx-DNA chip surface. Hence the GCN
component does not mediate DNA binding.
Finally, all three proteins showed very similar sensorgrams
when passed over the helE35Q-DNA chip (Figure 6B). Their
traces did not reveal any significant protein–DNA interactions
and differed only in their signal heights. Only a very slight
retardation in the dissociation of ToxR0(DTM)GCN from the
hel chip indicates that some non-specific ToxR0(DTM)GCN–
helE35Q interactions might have occurred and appear to be
even more stable than ToxR0(DTM)–ctx interactions.
Overall, the mobility shift and SPR data show that the cyto-
plasmic ToxR module ToxR0(DTM) binds DNA with only low
specificity. In contrast, ToxR0(DTM)GCN exhibits strong
specificity for ctx-DNA, corroborating the notion that dimer-
ization is a prerequisite for efficient and specific DNA binding
by ToxR.
Discussion
Even though the ToxR system offers the advantages of proka-
ryotic two-hybrid systems and, moreover, provides a broader
potential application range than the systems described to date,
it has not yet been widely implemented for protein–protein
interaction studies. This may be due in part to the fact that
the molecular basis of ToxR’s function as a transcriptional
activator of the ctx promoter in E.coli is still only poorly
understood. We have investigated the minimal requirements
for specific DNA binding and for ctx promoter activation by
ToxR in E.coli and have extended the ToxR system to the study
of protein heterodimerization. Our work contributes to the
understanding of the structure–function relationship in ToxR
as a prerequisite for the enhancement of ToxR’s use as a
prokaryotic two-hybrid system.
Requirements for specific DNA binding and transcriptional
activation by ToxR
We have shown that the soluble ToxR0(DTM) and
ToxR0(DTM)GCN proteins form dimers and higher order oli-
gomers in vitro, respectively, suggesting that the N-terminal
cytoplasmic ToxR module harbors previously unidentified
interaction sites. We have confirmed that oligomerization is
not mediated by a short fragment of the periplasmic ToxR
domain (region X) present in all ToxR fusion proteins. The
existence of additional interaction sites in the N-terminal
DNA-binding module of ToxR has consequences for the
applicability of ToxR as a genetic indicator for protein–
protein interactions, since it might cause misleadingly high
transcriptional activities particularly for ToxR fusion proteins
with only weakly interacting C-terminal fusion partners.
Therefore, we have identified the region in the N-terminal
ToxR module responsible for in vitro oligomerization and
asked whether this region affects ToxR function. Our data
show that in vitro ToxR–ToxR interactions are mediated by
a short hinge region, which in the full-length ToxR protein lies
between the wHTH motif and the transmembrane segment
(amino acids 139–181). The hinge region, however, is neither
required for specific ctx-DNA binding in vitro nor for ctx
promoter activation in E.coli, suggesting that the wHTH
motif of the N-terminal ToxR domain in fusion with a dimer-
izing protein module is sufficient to activate transcription at ctx
in E.coli. We have not yet tested whether the hinge region can
also be deleted from membrane-anchored ToxR derivatives
without loss of function. Possibly it confers flexibility on
the N-terminal domain of membrane-anchored ToxR proteins
that is required to allow its association into a functional dimeric
state (see discussion below). Finally, the identification of the
hinge region in ToxR’s N-terminal domain as the site respons-
ible for mediating ToxR–ToxR interactions may also be
of biological relevance. Using a system that reports via
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transcriptional activation of a PRM–lacZ fusion, it has previ-
ously been shown that ToxR dimers are capable of interacting
cooperatively and that these interactions are mediated by its
cytoplasmic module (Dziejman et al., 1999). Hence the hinge
region would be a primary candidate for an interaction site that
is responsible for these cooperative interactions. Although they
may not be important for binding and activation of ctx (our data
do not support a role of cooperative ToxR interactions in ctx
binding and activation in E.coli and in V.cholerae the direct
involvement of ToxR in ctx activation remains uncertain), they
may still be relevant for the ToxR-mediated regulation of other
ToxR-regulon genes in V.cholerae. Cooperative ToxR inter-
actions have, for example, been suggested to play a role in
the binding and activation of the ompU promoter (Crawford
et al., 1998).
One question that arises from our studies is why
ToxR0(DTM) dimerizes in vitro but does not activate transcrip-
tion at ctx in vivo. Our electrophoretic mobility shift assays
show that the isolated cytoplasmic ToxR0(DTM) module in
principle is capable of binding to DNA but that it acquires
specificity for the ctx promoter sequence only in fusion with
a dimerizing protein module (e.g. GCN4). Binding of
ToxR0(DTM) to ctx required a protein concentration that
also resulted in unspecific interactions with the hel control
DNA (protein:DNA ratio of 800:1). In contrast, first
ToxR0(DTM)GCN–ctx complexes were observed at a pro-
tein:DNA ratio of 100:1. Moreover, the ToxR0(DTM)GCN
protein interacted more strongly with the ctx fragment than
ToxR0(DTM), as indicated by its slow dissociation from ctx
in SPR experiments. Hence the GCN-mediated dimeriza-
tion of ToxR0(DTM) increases its DNA-binding specificity.
Furthermore, ToxR0(DTM)GCN bound ctx in a
concentration-dependent manner, suggesting the existence of
multiple binding sites which are occupied successively by mul-
tiple ToxR molecules. The seven tandemly repeated copies of
the TTTTGAT heptad in the ctx promoter fragment are primary
candidates for such multiple ToxR binding sites. This would
also be consistent with earlier observations that ToxR requires
multiple TTTTGAT direct repeats upstream of the ctxAB struc-
tural genes for binding and that promoter activity as well as the
apparent relative strength of the ToxR–ctx interaction increases
with the number of repeats (Miller and Mekalanos, 1984;
Miller et al., 1987; Pfau and Taylor, 1996). Overall, we con-
clude that dimerization of ToxR0(DTM) and ToxR0(DTM)GCN
involves different surfaces of the cytoplasmic ToxR module,
such that the ToxR0(DTM)GCN but not the ToxR0(DTM) dimer
is sterically qualified to interact specifically with the ctx pro-
moter sequence. Finally, deletion of the hinge region from
ToxR0(DTM)GCN did not affect its interaction with the ctx
and hel fragments, indicating that the oligomerization of ToxR
dimers does not alter their DNA-binding specificity and that
oligomerization is not required for a rapid and complete
occupation of ctx in vitro.
A ToxR-based prokaryotic two-hybrid system
Currently, two systems exist that use ToxR as a genetic
indicator for folding stability (Kolmar et al., 1995b) and for
interactions between heterologous protein modules or
membrane-spanning protein domains (Kolmar et al., 1994,
1995a,b; Langosch et al., 1996; Russ and Engelman, 1999).
Both systems are based on the original notion that the activity
of ToxR as a transcriptional activator of ctx in E.coli depends
on the dimerization of its cytoplasmic DNA-binding domain
(Miller et al., 1987; DiRita and Mekalanos, 1991) and both take
advantage of the finding that the periplasmic domain of ToxR
and its transmembrane segment can be replaced individually by
heterologous protein modules without loss of function. The
ToxR system developed by Kolmar et al. (1994) and used
in this study assays dimerization-induced ctx activation by
monitoring b-galactosidase activity originating from a single
chromosomal copy of the ctx::lacZ reporter fusion (E.coli
strain FHK12). The various ToxR constructs are constitutively
produced from a phasmid vector. Besides its applicability to
study symmetric interactions of heterologous fusion partners in
the periplasm of E.coli, this system has also been shown to be a
useful tool for the detection of protein homodimerization in the
E.coli cytoplasm (Kolmar et al., 1994, 1995a). Using the leu-
cine zippers Jun and Fos as model proteins for heterodimer-
ization, we have shown here that the ToxR system also allows
the detection of asymmetric protein interactions in both cellular
compartments of E.coli. Consistent with similar association
constants of 107 M1 for GCN and for Jun/Fos, respectively
(Blondel and Bedouelle, 1991; Pernelle et al., 1993), the tran-
scriptional activity of the co-produced membrane-anchored
and soluble ToxR-Fos/Jun proteins was comparable to that
of the respective homodimerizing ToxR-GCN fusion proteins.
We were not able, however, to monitor Jun/Jun homodimer-
ization even though at least the membrane-anchored
ToxR0MalEJun protein was present in the cells at a level com-
parable to ToxR0MalEGCN. One possible explanation for this
lack of detectable transcriptional activity may be a lower
stability of Jun/Jun homodimers as compared with Fos/Jun
heterodimers. Studies performed by Smeal et al. (1989) are
in support of this assumption, although to our knowledge an
association constant has not yet been determined for the
Jun/Jun homodimer. However, the failure to measure
ToxR0MalEJun-mediated transcriptional activation of ctx sug-
gests that it may be lower than the detectable threshold value
of the ToxR system. The determination of this threshold value
would therefore be a valuable contribution to the enhancement
of the ToxR system.
Another aspect of ToxR’s technical utility is reflected in the
TOXCAT assay, which was developed to study the association
of transmembrane helices in a natural membrane environment
(Russ and Engelmann, 1999). TOXCAT uses a plasmid-
encoded ctx:chloramphenicol acetyl transferase (CAT)
reporter fusion to measure ctx activation by quantifying chlor-
amphenicol acetylation by CAT in vitro or by acquired resist-
ance to chloramphenicol in vivo. The chimeric toxR genes are
located on the same plasmid under control of a lac promoter to
allow a modulation of their cellular concentration.
Overall, the ToxR system provides the advantages that
E.coli-based two-hybrid systems have over the yeast two-
hybrid system (for a review, see Hu et al., 2000), but, by
allowing the analysis of periplasmic and transmembrane
protein–protein interactions, offers an even broader potential
application range than the prokaryotic two-hybrid systems
described to date (e.g. Hu et al., 1990; Dove et al., 1997;
Dmitrova et al., 1998; Karimova et al., 1998; Di Lallo et al.,
2001). Moreover, the option to study interactions in the peri-
plasm of E.coli provides a promising basis for the expansion of
the ToxR system towards screening of low molecular weight
compounds to study ligand-binding or ligand-induced con-
formational changes, since it obviates the necessity for such
DNA binding and transcriptional activation by ToxR
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compounds supplied externally with the E.coli growth medium
to pass the cytoplasmic membrane. In this context, the ToxR
system could furthermore be adjusted for high-throughput
screening by converting it into a mating-based, conjugative
system, as has recently been described for the LexA-based
prokaryotic two-hybrid system (Clarke et al., 2005).
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